Wealthy gain as world demands fair access
May 05, 2021 | 08:00
While some of the world’s largest vaccine makers have committed to increase COVID-19 vaccine access to middle and low-income countries, there remains uncertainty over patent waivers.
Pharmaceutical giants shell out billions to shareholders amid vaccine apartheid
April 26, 2021 | 15:10
Pfizer, Johnson & Johnson, and AstraZeneca have paid enough in dividends and stock buybacks to shareholders to inoculate the population of Africa.
Replaced regulation to hit global drugmakers
July 16, 2020 | 14:00
International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.
US groups flock to ASEAN to further aid business interests
March 12, 2020 | 08:00
Betting on Vietnam’s future growth potential driven by landmark free trade agreements, investors from both the United States and the ASEAN are releasing new plans to venture further into the lucrative local market, with healthcare being a heavy focus.
Drug price hikes in US threaten the same in Vietnam?
January 06, 2020 | 12:04
Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.
1 2
Mobile Version